Every earnings call for MEDANTA — management tone, guidance, KPIs and promise tracking, quarter by quarter.
MEDANTA · 6 transcripts · Healthcare · latest Q4 FY26Global Health Limited has 6 earnings calls on record here, a Healthcare company, most recently Q4 FY26. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.
EBITDA (ex-Noida, Q4 FY26) 3142 million (+27% YoY); EBITDA Margin (ex-Noida, Q4 FY26) 27.5%; PAT (Q4 FY26) 1417 million (+40% YoY). Total income grew by 25% YoY to INR 11,958 million in Q4 FY26.
Read full transcript & analysisEBITDA (incl. Noida) 2494 millions; EBITDA Margin (excl. Noida) 25.4%; Adjusted PAT 1224 millions. Total income reached ₹11,428 million, representing a robust 19% YoY growth.
Read full transcript & analysisEBITDA (including Noida) 2607 million (+6% YoY); EBITDA Margin (including Noida) 23.3%; PAT 1584 million (+21% YoY). Consolidated Total Income reached ₹11,189 million, representing a strong 15% YoY growth.
Read full transcript & analysisEBITDA ₹255 cr (+23% YoY); EBITDA Margin 24.3%; PAT ₹159 cr (+50% YoY). Total income of ₹1,051.3 crores, up 19% YoY.
Read full transcript & analysisEBITDA Margin 25.4%; Adjusted PAT 5186 million (+9% YoY); Total Income 37714 million (+13% YoY). FY25 Consolidated Income reached ₹37,714 million, a 13% YoY growth.
Read full transcript & analysisEBITDA ₹254 cr (+8% YoY); EBITDA Margin 27.5%; PAT ₹143 cr (+16% YoY). Total Income reached ₹959.5 crores, representing a 12% YoY growth.
Read full transcript & analysis